Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects ...United Arab Emirates

Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in mid-2024.

Hence then, the article about pfizer to discontinue twice daily weight loss pill due to high rates of adverse side effects was published today ( Friday 01/12/2023 - 02:53 PM ) and is available on CNBC ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects )

Also on site :

• Small Modular Reactors Are the Perfect Fit for Kazakhstan’s Power Grid
• Why China Is Driving Short-Term Oil Prices But OPEC Still Holds the Lever
• China Passes Amendments to Foreign Trade Law to Boost Trade War Capabilities